Abstract:Despite recent advances in biomolecular research that have improved our knowledge of cholesteatoma pathogenesis, the reasons behind its highly variable clinical course are still not clarified. It has been proposed that biological signaling between peri-matrix and matrix cells could play a critical role in disease homeostasis. The aim of our study was to analyze the expression of inflammatory (IL-1β), hyper-proliferative (STAT-3, TGF-β), and angiogenic (VEGF-C, PDGFr) factors in congenital and acquired cholesteatomas (both in adults and children), which might correlate with the clinical features observed. We performed an experimental study on 37 patients (29 males and 8 females, ranging from 4 to 66 years of age) who were diagnosed with cholesteatoma between 2020 and 2021 in our institution. All patients underwent clinical, audiologic, and radiologic assessments. Bone erosion grading and staging of cholesteatoma growth were assessed through preoperative evaluation and intraoperative middle ear findings, according to the PTAM System proposed by the Japan Otological Society (2016). Retro-auricular skin specimens were intraoperatively collected in all patients. Skin and cholesteatoma samples were analyzed through histopathological, western blot, and immunohistochemical evaluations. The expression rate was measured to find out the differences between congenital and acquired cholesteatomas as well as between the adult and pediatric populations. Expression of angiogenic, inflammatory, and proliferative biomarkers is significantly increased in acquired cholesteatomas in children as compared to congenital and acquired forms in adults, in accordance with the higher stage of disease shown by imaging, surgical, and histological features. Our data suggest that pathways already supposed to be involved in the pathogenesis of cholesteatomas could be differently activated in more destructive forms, typically found in children. The identification of potential biomarkers of cholesteatoma aggressiveness could lead to more personalized management (timing of intervention, recurrence prevention) and the future identification of anti-growth/anti-proliferative agents as non-surgery therapeutic options.

The Expression and Significance of Interleukin-1-alpha in Human Middle Ear Cholesteatoma and Granulation Tissue

Expressions of MMP-1,MMP-8 and MMP-13 in gingival tissue of patients with aggressive periodontitis

The Expression and Significance of Heat Shock Protein 70 and Proliferating Cell Nuclear Antigen Protein in Human Middle Ear Cholesteatoma

Enhanced Mitophagy in Cholesteatoma Epithelial Cells.

Expressions of EGFR and Phosphotyrosine in Human Middle Ear Cholesteatoma

A study of the protein tyrosine kinases pathway in human middle ear cholesteatoma

Immunohistochemical Discrimination of Aggressivity Between the Cholesteatoma from Different Positions

44-plex cytokine profile of cholesteatoma

High-mobility group box protein 1 expression in inflammatory diseases of the middle ear

Role of Autophagy in Acquired Cholesteatoma

Expression of matrix metalloproteinnse-2,9 in cholesteatoma from different positions

Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study

Induction of Cytokine Production in Cholesteatoma Keratinocytes by Extracellular High-Mobility Group Box Chromosomal Protein 1 Combined with DNA Released by Apoptotic Cholesteatoma Keratinocytes

Immune Suppressive Function of IL-1α Release in the Tumor Microenvironment Regulated by Calpain 1.

Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma

Comparison of Tissue Factors in the Ontogenetic Aspects of Human Cholesteatoma

Regional Differences of Mouse Utricle Hair Cells Proliferation and Differentiation and Establishment of the Planar Cell Polarity

Expression of MUC5AC and TNF-αin Middle Ear Mucosa in a Rat Model of Acute Otitis Media With Effusion

Biochemical basis for the toxic effects of triethyl lead

Cathelicidin Antimicrobial Peptide Ll-37 in Cholesteatoma Enables Keratinocyte Reactivity with Cytosolic Dna

Study of Angiogenic, Pro-Apoptotic, and Pro-Inflammatory Factors in Congenital and Acquired Cholesteatomas